Loading clinical trials...
Loading clinical trials...
A Phase I Randomized, Double-Blind Trial of the Safety and Immunogenicity of FluMist® A Live, Intranasal Influenza Virus Vaccine vs. Placebo in Immunocompromised Children Ages 5 Through 17 Years of Age
Conditions
Interventions
FluMist
Placebo
Locations
5
United States
University of Rochester School of Medicine & Dentistry
Rochester, New York, United States
Stony Brook University Medical Center
Stony Brook, New York, United States
St. Jude's Children's Research Hospital
Memphis, Tennessee, United States
Vanderbilt University
Nashville, Tennessee, United States
Children's Hospital Regional Medical Center
Seattle, Washington, United States
Start Date
August 1, 2005
Primary Completion Date
March 1, 2008
Completion Date
May 1, 2008
Last Updated
August 14, 2017
NCT05468034
NCT04541381
NCT07446322
NCT06844383
NCT05671510
NCT05398783
Lead Sponsor
MedImmune LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions